These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19191299)

  • 1. Pseudomonas aeruginosa biofilms in a bronchoalveolar lavage.
    Pusztaszeri M; Aubert JD; Braunschweig R; Mihaescu A
    Diagn Cytopathol; 2009 Nov; 37(11):825. PubMed ID: 19191299
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracellular DNA required for bacterial biofilm formation.
    Whitchurch CB; Tolker-Nielsen T; Ragas PC; Mattick JS
    Science; 2002 Feb; 295(5559):1487. PubMed ID: 11859186
    [No Abstract]   [Full Text] [Related]  

  • 3. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Aaron SD; Kottachchi D; Ferris WJ; Vandemheen KL; St Denis ML; Plouffe A; Doucette SP; Saginur R; Chan FT; Ramotar K
    Eur Respir J; 2004 Oct; 24(4):631-7. PubMed ID: 15459143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
    Manos J; Arthur J; Rose B; Bell S; Tingpej P; Hu H; Webb J; Kjelleberg S; Gorrell MD; Bye P; Harbour C
    FEMS Microbiol Lett; 2009 Mar; 292(1):107-14. PubMed ID: 19222585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycerol metabolism promotes biofilm formation by Pseudomonas aeruginosa.
    Scoffield J; Silo-Suh L
    Can J Microbiol; 2016 Aug; 62(8):704-10. PubMed ID: 27392247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaerobic biofilm infections in cystic fibrosis.
    Costerton JW
    Mol Cell; 2002 Oct; 10(4):699-700. PubMed ID: 12419212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.
    Nguyen D; Singh PK
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8305-6. PubMed ID: 16717189
    [No Abstract]   [Full Text] [Related]  

  • 10. Biofilm dispersal and exacerbations of cystic fibrosis lung disease.
    Reid DW; Kirov SM; Webb JS; Carroll V; Kjelleberg S; Champion A; Sanderson K
    Pediatr Pulmonol; 2006 Dec; 41(12):1254; author reply 1255. PubMed ID: 17068827
    [No Abstract]   [Full Text] [Related]  

  • 11. How reliable are cough swabs for the detection of Pseudomonas aeruginosa in adult patients with cystic fibrosis?
    Moore JE; McCaughan J; McNeilly J; Rendall JC; Downey DG
    Br J Biomed Sci; 2015; 72(4):206. PubMed ID: 26738405
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbiology: a resistance switch.
    O'Toole GA
    Nature; 2002 Apr; 416(6882):695-6. PubMed ID: 11961541
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients.
    Döring G; Taccetti G; Campana S; Festini F; Mascherini M
    Eur Respir J; 2006 Mar; 27(3):653. PubMed ID: 16507869
    [No Abstract]   [Full Text] [Related]  

  • 14. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron, Pseudomonas aeruginosa and cystic fibrosis.
    Reid DW; Kirov SM
    Microbiology (Reading); 2004 Mar; 150(Pt 3):516. PubMed ID: 14993297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments.
    Brugha RE; Davies JC
    Br J Hosp Med (Lond); 2011 Nov; 72(11):614-9. PubMed ID: 22083001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of seeding dispersal in biofilms.
    Kirov SM; Webb JS; Kjelleberg S
    Microbiology (Reading); 2005 Nov; 151(Pt 11):3452-3453. PubMed ID: 16272368
    [No Abstract]   [Full Text] [Related]  

  • 20. [What microbiological criteria define a colonization or an infection with Pseudomonas aeruginosa?].
    Plésiat P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S84-9. PubMed ID: 12910139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.